Analysis: Why it's crucial that news outlets get it right when covering adverse coronavirus vaccine reactions - News Summed Up

Analysis: Why it's crucial that news outlets get it right when covering adverse coronavirus vaccine reactions


New York (CNN Business) A version of this article first appeared in the "Reliable Sources" newsletter. A push alert from NYT added, "It's unclear if the case has broader safety implications." The push alert specifically raised eyebrows. "Debate the merits of doing this as a push alert," tweeted Snapchat's Peter Hamby. We actually have solid safety data for the Pfizer vaccine from the phase 3 efficacy trial and the vaccine appears safe in the group in which it was studied."


Source: CNN December 17, 2020 04:40 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */